| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.64B | +2.0% |
| Cost of Revenue | $3.87B | +0.4% |
| Gross Profit | $1.77B | +5.5% |
| R&D Expense | $102.5M | +2.7% |
| SG&A Expense | $786.2M | +1.8% |
| Operating Income | $944.8M | +4.9% |
| Interest Expense | $162.3M | -3.3% |
| Pre-tax Income | $729.3M | +1.8% |
| Income Tax | $238.0M | +5.8% |
| Net Income | $491.6M | -3.0% |
| EPS (Basic) | $3.37 | +0.3% |
| EPS (Diluted) | $3.33 | +0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $456.1M | -18.7% |
| Accounts Receivable | $592.4M | -4.5% |
| Inventory | $866.3M | +19.4% |
| Current Assets | $2.12B | +2.3% |
| Total Assets | $6.21B | -0.2% |
| Current Liabilities | $2.08B | +3.7% |
| Long-term Debt | $3.70B | -1.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $613.3M | -13.6% |
| Capital Expenditures | $237.3M | +11.4% |
| Investing Cash Flow | -$243.0M | -93.3% |
| Financing Cash Flow | -$446.7M | +22.4% |
| Free Cash Flow | $376.0M | -24.3% |
| Total Liabilities |
| $5.87B |
| -1.8% |
| Stockholders' Equity | $344.1M | +38.4% |